
2026 Speakers

- Jun Bao
- Founder & Managing Partner
- APURI BIOVENTURE

- Tess Cameron
- Managing Director
- RA CAPITAL

- Cyber Cao
- Managing Director
- HSG

- Anna Chen
- Partner
- FRAZIER LIFE SCIENCE

- Claire Chen
- Managing Director
- HANKANG CAPITAL

- Cynthia Chen
- Chairlady, Executive Director & President
- PULNOVO MEDICAL

- Kan Chen
- Co-Head of Healthcare & Partner
- QIMING VENTURE PARTNERS

- Michael Chen
- Chief Business Officer
- DARWIN BIOTECHNOLOGY

- Cui Cui
- Managing Director, Head of Asia Healthcare Research
- JEFFERIES

- Paul Cui
- Head of Global Market Insights
- IQVIA

- Charles Ding
- President
- VYBIO

- Dandan Dong
- Venture Partner
- TCGX

- Jianmin Fang
- Co-Founder & Chief Executive Officer
- REMEGEN BIOSCIENCE

- Lei Fang
- Co-Founder,Chairman & Chief Executive Officer
- EXCALIPOINT THERAPEUTICS

- Felix Fei
- Assurance Leader, China Central & Health Sciences and Wellness Sector Co-leader, Greater China
- Ernst & Young

- Jun Feng
- Chief Executive Officer
- ENCHANNEL MEDICAL

- Yan Feng
- Chief Executive Officer
- Leadingtac Pharmaceuticals

- Yun Gao
- Principal
- LILLY ASIA VENTURES

- Sheng Han
- Vice Director, International Research Center of Medicinal Administration
- PEKING UNIVERSITY

- Nanhai He
- Vice President, Global Drug Discovery
- ADLAI NORTYE

- Tina Hou
- Partner
- MCKINSEY & COMPANY

- Wei Hu
- Chief Executive Officer
- ATTEC BIOTECHNOLOGY

- Jerry Lee
- Global Chair of Investment Banking
- JP MORGAN

- Bin Li
- Founder and Chief Investment Officer
- LAKE BLEU CAPITAL

- James Li
- Venture Partner
- FRAZIER LIFE SCIENCES

- Jason Li
- Chief Financial Officer
- MEDILINK THERAPEUTICS

- Meng Li
- Economist / Assistant Professor
- STIFEL FINANCIAL CORP / TUFTS UNIVERSITY

- Song Li
- Head of Innovative Drugs
- Matwings

- Alice Liu
- Sales & Marketing Director
- KINGSTRONBIO

- Alex Lu
- Chief Executive Officer, China
- BRIOHEALTH SOLUTIONS

- Bai Lu
- Director
- Shanghai Academy of Natural Sciences

- Qiang Lu
- Co-Founder & Chairman
- GENFLEET THERAPEUTICS

- Xin Ma
- Chief Executive Officer
- SPECTRUM DYNAMICS MEDICAL

- Frank Nestle
- Partner and Chief Executive Officer
- DEERFIELD, 3DC

- Fei Pu
- Director & General Manager
- LEPU MEDICAL TECHNOLOGY

- Yiping Rong
- Chief Scientific Officer
- HARBOUR BIOMED

- Ioannis Sapountzis
- Chief Executive Officer & Chairman
- BOEHRINGER INGELHEIM CHINA

- Fei Shen
- Head of BD&L USA & Global TA Inflammation
- BOEHRINGER INGELHEIM

- Yonghui Shi
- Executive Director, Senior Vice President
- MICROTECH MEDICAL

- Jeffrey Su
- Chief Executive Officer
- MARINA BIOTHERAPEUTICS

- Lanny Sun
- Chief Executive Officer & Chairman
- FULL-LIFE TECHNOLOGIES

- John Wang
- Senior Vice President of Small Molecule Drug Discovery and Technology
- XTALPI

- Lai Wang
- President, Global Head of R&D
- BEONE

- Wilson Wang
- Head of Corporate Development
- CREATERNA

- Michael Wen
- Co-President
- HANGZHOU TIGERMED CONSULTING

- Jane Wu
- Managing Director
- JP MORGAN

- Marietta Wu
- Managing Director
- QUAN CAPITAL

- Richard Xie
- Senior Health Economist
- RA CAPITAL MANAGEMENT

- Cindy Xiong
- Partner
- FORESITE CAPITAL

- Jing Xu
- Vice President, Head of Global Strategy
- SCIWIND BIOSCIENCES

- Wei Xu
- Chief Scientific Officer
- METIS TECHBIO

- Dajun Yang
- Chairman of the Board, Executive Director & Chief Executive Officer
- ASCENTAGE PHARMA

- Jenny Yang
- Head of External Innovation Asia Pacific
- NOVO NORDISK A/S

- Liyuan Yang
- Vice President ,Head of Business Development China
- BRISTOL MYERS SQUIBB

- Yingying Yang
- Partner
- QUAN CAPITAL

- Mao Yin
- Founder & Chief Scientific Officer
- PRIMELINK BIOTHERAPEUTICS

- Yu Yu
- Chief Executive Officer
- PLERYON THERAPEUTICS

- Yuan Yuan
- Head of Platform Development, China
- NEXTBIO CAPITAL

- Man Zhang
- Senior Vice President, Head of biology and translational medicine
- INSILICO MEDICINE

- Sean Zhang
- Executive Director
- VIVO CAPITAL

- Shuo Zhang
- Associate Portfolio Manager
- BALYASNY ASSET MANAGEMENT

- Weian Zhao
- Founder & Chief Executive Officer
- AUREKA BIOTECHNOLOGIES

- Yangbing Zhao
- President & Chief Scientific Officer
- UTC THERAPEUTICS

- Dan Zheng
- Head of Regional Innovation and Partnerships
- TAKEDA PHARMACEUTICALS

- Jason Zhu
- Executive Director & Chief Executive Officer
- HENLIUS

- Jie Zhu
- Partner
- Wilson Sonsini Goodrich & Rosati
